Search Results: PARP

• Health & Medicine

Advanced ovarian cancer treatment approved for Cancer Drugs Fund

A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund. A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund.

11 October 2019

• Health & Medicine

Advanced ovarian cancer drug gets initial ‘no’ for NHS in England

A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England. A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.

9 August 2019

• Health & Medicine

Ovarian cancer drug will be offered earlier to NHS patients in England

A targeted drug for advanced ovarian cancer will be more widely available for certain patients on the NHS in England. A targeted drug for advanced ovarian cancer will be more widely available for certain patients on the NHS in England.

26 July 2019

• Health & Medicine

Targeted drug trial points to potential ‘new age’ for pancreatic cancer treatment

A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy. A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy.

2 June 2019

• Science & Technology

ASCO 2019 news: targeted treatment takeover, drugging the ‘undruggable’, obesity and blood tests

The 2019 ASCO conference news highlights: a year of progress with targeted drugs trialled in prostate, pancreatic, breast and lung cancers. The 2019 ASCO conference news highlights: a year of progress with targeted drugs trialled in prostate, pancreatic, breast and lung cancers.

31 May 2019

• For Researchers

Promoting an academic culture of entrepreneurship at our first Innovation Summit

Our Innovation Summit and Innovation Prizes are creating new opportunities to develop the translational and commercial potential of your breakthrough science. Our Innovation Summit and Innovation Prizes are creating new opportunities to develop the translational and commercial potential of your breakthrough science.

1 April 2019

• Science & Technology

International Women’s Day: a Wikipedia edit-a-thon for women in cancer research 

Less than 1 in 5 Wikipedia biographies are about women. We wanted to change that. Less than 1 in 5 Wikipedia biographies are about women. We wanted to change that.

8 March 2019

• For Researchers

Celebrating a lifetime in cancer biology, an early diagnosis champion, and our leaders of tomorrow: the 2018 CRUK Research Prizes

We've awarded our annual research prizes at the NCRI Conference in Glasgow. Find out who won our Future Leaders, Jane Wardle, and Lifetime Achievement prizes. We've awarded our annual research prizes at the NCRI Conference in Glasgow. Find out who won our Future Leaders, Jane Wardle, and Lifetime Achievement prizes.

19 December 2018

• Health & Medicine

Targeted drug could slow progression of ovarian cancer in women with faulty BRCA gene

A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new research. A drug could help slow the progression of some advanced ovarian cancers and extend the time that patients show no signs of disease, according to new research.

24 October 2018

• Science & Technology

How can CRISPR genome editing shape the future of cancer research?

CRISPR genome editing has received lots of attention and hype, so we took a look at what it really means for the future of cancer research. CRISPR genome editing has received lots of attention and hype, so we took a look at what it really means for the future of cancer research.

12 January 2018